Prevention of Epstein-Barr (EB) Virus-induced Lymphoma in Cottontop Tamarins by Vaccination with the EB Virus Envelope Glycoprotein gp340 Incorporated into Immune-stimulating Complexes

References

1. BURKITT D. 1963 A lymphoma syndrome in tropical Africa. International Review of Experimental Pathology 267–138 Edited by Richter G. W., Epstein M. A. New York & London: Academic Press;
   [Google Scholar]
2. CLEARY M. L., EPSTEIN M. A., FINERTY S., DORFMAN R. F., BORNKAMM G. W., KIRKWOOD J. K., MORGAN A. J., SKLAR J. 1985; Individual tumors of multifocal EB virus-induced malignant lymphomas in tamarins arise from different B-cell clones. Science 228:722–724
   [Google Scholar]
3. DALSGAARD K. 1978; A study of the isolation and characterisation of the saponin Quil A. Evaluation of its adjuvant activity with special reference to the application in the vaccination of cattle against foot-and-mouth disease. Acta veterinaria scandinavica supplement 69:1
   [Google Scholar]
4. DAVID E. M., MORGAN A. J. 1988; Efficient purification of Epstein-Barr virus membrane antigen gp340 by fast protein liquid chromatography. Journal of Immunological Methods 108:231–236
   [Google Scholar]
5. DE SCHRYVER A., KLEIN G., HENLE W., HENLE G. 1974; EB virus-associated antibodies in Caucasian patients with carcinoma of the nasopharynx and in long-term survivors after treatment. International Journal of Cancer 13:319–325
   [Google Scholar]
6. DORFMAN R. F., BURKE I. S., BERARD C. 1982 A working formulation of non-Hodgkins lymphomas: background recommendations, histological criteria, and relationship to other classifications. Malignant Lymphomas351–368 Edited by Rosenberg S., Kaplan H. New York & London: Academic Press;
   [Google Scholar]
7. EPSTEIN M. A. 1976; Epstein-Barr virus — is it time to develop a vaccine program?. Journalofthe National Cancer Institute 56:697–700
   [Google Scholar]
8. EPSTEIN M. A., MORGAN A. J. 1987 Progress with subunit vaccines against the virus. The Epstein-Barr Virus: Recent Advances271–289 Edited by Epstein M. A., Achong B. G. London: Heinemann;
   [Google Scholar]
9. EPSTEIN M. A., MORGAN A. J., FINERTY S., RANDLE B. J., KIRKWOOD J. K. 1985; Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine. Nature, London 318:287–289
   [Google Scholar]
10. FINERTY S., SCULLION F. T., MORGAN A. J. 1988; Demonstration in vitro of cell mediated immunity to Epstein-Barr virus in cottontop tamarins. Clinical and Experimental Immunology in press
    [Google Scholar]
11. FRIZZERA G., HANTO D. W., GAJL-PECZALSKA J., ROSAI J., MCKENNA R. W., SIBLEY R. K., HOLAHAN K. P., LINDQUIST L. L. 1981; Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Research 41:4262–4279
    [Google Scholar]
12. HENLE G., HENLE W. 1966; Immunofluorescence in cells derived from Burkitt’s lymphoma. Journal of Bacteriology 91:1248–1256
    [Google Scholar]
13. HOWARD C. R., SUNDQUIST B., ALLAN J., BROWN S. E., CHEN S.-H., MOREIN B. 1987; Preparation and properties of immune-stimulating complexes containing hepatitis B virus surface antigen. Journal of General Virology 68:2281–2289
    [Google Scholar]
14. LOVGREN K., LINDMARK J., PIPKORN R., MOREIN B. 1987; Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier. Journal of Immunological Methods 98:329–356
    [Google Scholar]
15. MILLER G., SHOPE T., LISCO H., STITT D., LIPMAN M. 1972; Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leucocytes. Proceedings of the National Academy of Sciences, U.S.A 69:383–387
    [Google Scholar]
16. MOREIN B., LOVGREN K., HOGLAND S., SUNDQUIST B. 1987; The iscom: an immunostimulating complex. Immunology Today 8:333–338
    [Google Scholar]
17. MORGAN A. J., MACKETT M., FINERTY S., ARRAND J., EPSTEIN M. A. 1988; Recombinant vaccinia virus expressing Epstein-Barr virus glycoprotein gp340 protects cottontop tamarins against EB virus-induced malignant lymphomas. Journal of Medical Virology in press
    [Google Scholar]
18. OSTERHAUS A., WEDER K., UYTDEHAAG F., JARRET O., SUNDQUIST B., MOREIN B. 1985; Induction of protective immune response in cats by vaccination with feline leukemia virus iscom. Journal of immunology 135:591–596
    [Google Scholar]
19. RANDLE B., EPSTEIN M. A. 1984; A highly sensitive enzyme-linked immunosorbant assay to quantitate antibodies to Epstein-Barr virus membrane antigen gp340. Journal of Virological Methods 9:201–208
    [Google Scholar]
20. SHANMUGARATNAM K. 1971 Studies on the etiology of nasopharyngeal carcinoma. International Review of Experimental Pathology 10361–413 Edited by Richter G. W., Epstein M. A. New York & London: Academic Press;
    [Google Scholar]
21. SPELTERS G., DANSE L., BEUVERY E., STRIK I., VOS I. 1988; Local reactions of the saponin Quil A and a Quil A-containing iscom measles vaccine after intramuscular injection of rats: a comparison with the effects of DPT-polio vaccine. Fundamental and Applied Toxicology 10:425–430
    [Google Scholar]
22. SUNDQUIST B., LOVGREN K., HOGLUND S., MOREIN B. 1988; Influenza virus iscoms: biochemical characterisation. Vaccine 6:44–48
    [Google Scholar]
23. WAHREN B., NORDLUND S., AKESSON A., SUNDQUIST V.-A., MOREIN B. 1987; Monocyte and iscom enhancement of cell-mediated response to cytomegalovirus. Medical Microbiology and Immunology 176:13–19
    [Google Scholar]